Skip to main content
. 2015 Sep 5;32(8):742–756. doi: 10.1007/s12325-015-0233-1

Fig. 2.

Fig. 2

Sensitivity analyses of projected drug cost savings resulting from the introduction of Remsima; 20% discount scenario. M million